LinkedIn Profile

Access New Haven Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:newhavenpharmaceuticals 786122 May 30th, 2019 12:00AM New Haven Pharmaceuticals, Inc. 943 7.00 Open Pharmaceuticals May 30th, 2019 01:56PM May 30th, 2019 01:56PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Open Pharmaceuticals, Gastrointestinal, Cardiovascular Open 116 Washington Avenue North Haven CT US 06473 Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 17th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 16th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 15th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 14th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 13th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 12th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 11th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 10th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Feb 9th, 2018 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.